American authorities offer reinforcement doses COVID-19 for all adults

Pfizer companies and Moderna announced the Food and Bars Administration's decision, as at least 10 states had already begun offering strengthening doses for all adults.

The latest action simplifys what has so far been a confusing list of those who qualify, allowing anyone who is 18 years old and older to choose the reinforcer of one of the companies six months after their last dose of ) regardless of which vaccine they had the first.

Another step: Centers for Disease Control and Prevention should agree to approve Pfizer and Modern doses even among healthy young people. Its scientific advisers will debate the issue Friday. If the CDC agrees, tens of millions of other Americans may have three protective doses before the new year.

All three vaccines against COVIDD-19 used in the United States still offer strong protection against serious diseases, including hospital hospital and death, but protection against infection can fade over time. Earlier, the government had approved the reinforcers of Pfizer and BioNTech vaccines, as well as the similar Modern vaccine, only for specific groups, including elderly Americans and people with chronic health problems.

The movement to expand the vaccines comes as new cases of COVID-19 have steadily increased over the past two weeks, especially in countries where cold weather is pushing people in.

Incited by these disturbing trends, some states did not expect federal officials to act. Utah and Massachusetts were the last states to announce last week that they would offer strengthening doses for all adults.

The strengthening dose for all was the original goal of the Biden Administration. But in September, an FDA panel of advisers voted overwhelmingly against this idea based on the continued effectiveness of vaccines in most age groups. Instead, they approved an additional Pfizer dose only for those with health problems.

Since then, administration officials, including Dr. Anthony Fauci, have continued to argue with the use of reinforcements more widely, noting that even the softest infections in young people can cause “CO The long-term VID” and other complications.

Companies studied 10,000 adults of all ages and found that a strengthening dose restored protection against symptoms infection to about 95%, even when the delta version was on the rise. It's too early to know if this high level of protection will last longer after a third blow than after the second one, something companies will carefully follow.

More than 195 million Americans are completely vaccinated, taking two doses of Pfizer vaccines, or Modernna, or vaccine, with a single dose Johnson & Johnson. Over 30 million have already received a reinforcer.

Some experts worry that all attention to doses can damage efforts to reach 60 million Americans who have the right to be vaccinated but have not received vaccines. /voa